The mechanisms responsible for the favorable clinical course in multiple sclerosis (MS) remain unclear. In this longitudinal study, we assessed whether magnetic resonance imaging (MRI)-based changes in focal and diffuse brain damage are associated with a long-term favorable MS diseases course. We found that global brain and gray matter (GM) atrophy changes were milder in MS patients with long-standing disease (⩾30 years from onset) and favorable (no/minimal disability) clinical course than in sex-age-matched disable MS patients, independently of lesions accumulation. Data showed that different trajectories of volume changes, as reflected by mild GM atrophy, may characterize patients with long-term favorable evolution
Introduction: Gray matter (GM) atrophy is common in multiple sclerosis (MS), but the relationship wi...
Background: In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with di...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
The mechanisms responsible for the favorable clinical course in multiple sclerosis (MS) remain uncle...
Background: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objectives: To investigate spatial patterns of gray matter (GM) atrophy and their association with d...
BACKGROUND: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
AbstractGrey matter (GM) atrophy occurs early in primary progressive MS (PPMS), but it is unknown wh...
Brain atrophy appears to occur in patients with multiple sclerosis (MS) in excess of that associated...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
BACKGROUND: Brain atrophy, in excess of that seen with normal aging, has been observed early in the ...
Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Sclerosis (MS) ...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are rela...
Introduction: Gray matter (GM) atrophy is common in multiple sclerosis (MS), but the relationship wi...
Background: In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with di...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
The mechanisms responsible for the favorable clinical course in multiple sclerosis (MS) remain uncle...
Background: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objectives: To investigate spatial patterns of gray matter (GM) atrophy and their association with d...
BACKGROUND: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
AbstractGrey matter (GM) atrophy occurs early in primary progressive MS (PPMS), but it is unknown wh...
Brain atrophy appears to occur in patients with multiple sclerosis (MS) in excess of that associated...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
Objectives. Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using so...
BACKGROUND: Brain atrophy, in excess of that seen with normal aging, has been observed early in the ...
Both gray-matter (GM) atrophy and lesions occur from the earliest stages of Multiple Sclerosis (MS) ...
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Purpose: To identify the measures of focal and diffuse white matter (WM) abnormalities that are rela...
Introduction: Gray matter (GM) atrophy is common in multiple sclerosis (MS), but the relationship wi...
Background: In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with di...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...